Par Capital Management - ARALEZ PHARMACEUTICALS INC ownership

ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 55 filers reported holding ARALEZ PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.

Quarter-by-quarter ownership
Par Capital Management ownership history of ARALEZ PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$168,000
-97.5%
481,400
-89.1%
0.00%
-97.3%
Q1 2018$6,647,000
-21.2%
4,431,301
-25.4%
0.07%
-22.3%
Q4 2017$8,438,000
-42.4%
5,942,309
-7.2%
0.09%
-43.7%
Q3 2017$14,656,000
+69.6%
6,400,0000.0%0.17%
+72.2%
Q2 2017$8,640,000
-36.9%
6,400,0000.0%0.10%
-41.6%
Q1 2017$13,696,000
-51.5%
6,400,0000.0%0.17%
-55.0%
Q4 2016$28,224,000
-9.1%
6,400,0000.0%0.37%
-17.6%
Q3 2016$31,040,000
+47.0%
6,400,0000.0%0.45%
+28.0%
Q2 2016$21,120,000
+10.9%
6,400,000
+19.3%
0.35%
+14.8%
Q1 2016$19,046,0005,365,0000.30%
Other shareholders
ARALEZ PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 289,664$663,0000.49%
Bryn Mawr Capital Management, LLC 113,752$260,0000.27%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,644,583$3,766,0000.17%
Par Capital Management 6,400,000$14,656,0000.17%
SALZHAUER MICHAEL 106,293$243,0000.10%
ISTHMUS PARTNERS, LLC 160,491$368,0000.10%
Brown Advisory Securities, LLC 172,000$394,0000.08%
GSA CAPITAL PARTNERS LLP 468,795$1,074,0000.07%
FRANKLIN STREET ADVISORS INC /NC 99,229$227,0000.04%
Contrarius Investment Management Ltd 216,211$495,0000.03%
View complete list of ARALEZ PHARMACEUTICALS INC shareholders